Cargando…

A new paradigm shift in antithrombotic therapy

Decades after the introduction of oral anti-coagulants namely the vitamin K antagonist (VKA) Warfarin and antiplatelet agents such as Aspirin and Plavix, new classes of direct, small molecule, novel oral anti-coagulant medications and antiplatelet P2Y12 receptor inhibitors have recently become avail...

Descripción completa

Detalles Bibliográficos
Autores principales: Pudusseri, Anita, Shameem, Raji, Spyropoulos, Alex C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800773/
https://www.ncbi.nlm.nih.gov/pubmed/24155721
http://dx.doi.org/10.3389/fphar.2013.00133

Ejemplares similares